Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives-Reference-Cited by-同舟云学术

Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors (PPARs) in Dysregulated Metabolic Homeostasis, Inflammation and Cancer: Current Evidence and Future Perspectives

Published:2016-06-24 Issue:7 Volume:17 Page:999
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Laganà Antonio,Vitale Salvatore,Nigro Angela,Sofo Vincenza,Salmeri Francesca,Rossetti Paola,Rapisarda Agnese,La Vignera Sandro,Condorelli Rosita,Rizzo Gianluca,Buscema Massimo

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/17/7/999/pdf

Reference55 articles.

1. Peroxisome proliferator activated receptors at the crossroad of obesity, diabetes, and pancreatic cancer

2. The Mechanisms of Action of PPARs

3. n-3 Fatty Acids Preserve Insulin Sensitivity In Vivo in a Peroxisome Proliferator–Activated Receptor-α–Dependent Manner

4. PPAR-α as a Key Nutritional and Environmental Sensor for Metabolic Adaptation

5. Histopathology of pediatric nonalcoholic fatty liver disease

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrating UHPLC-Q-TOF-MS/MS, network pharmacology, bioinformatics and experimental validation to uncover the anti-cancer mechanisms of TiaoPi AnChang decoction in colorectal cancer;Journal of Ethnopharmacology;2024-11

2. A chemical modification of a peroxisome proliferator-activated receptor pan agonist produced a shift to a new dual alpha/gamma partial agonist endowed with mitochondrial pyruvate carrier inhibition and antidiabetic properties;European Journal of Medicinal Chemistry;2024-09

3. Effect of 23‑hydroxybetulinic acid on lung adenocarcinoma and its mechanism of action;Experimental and Therapeutic Medicine;2024-03-28

4. Immunogenetic Aspects of Sarcopenic Obesity;Genes;2024-02-05

5. Peroxisome Proliferator-Activated Receptor agonists and antagonists: an updated patent review (2020–2023);Expert Opinion on Therapeutic Patents;2024-02